Discover
NXL
Nexalin Technology, Inc.
0.38
2 x 0.27
2 x 0.46
bid
ask
+
0.05
15.15%
2 @ 04:00 PM
0.40 +0.02 (5.26%)
| Ytd | -31.90% | |
| 1y | -61.62% |
0.34
day range
0.40
0.30
52 week range
2.00
| Open | 0.36 | Prev Close | 0.33 | Low | 0.34 | High | 0.40 | Mkt Cap | 8.19M |
| Vol | 328.98K | Avg Vol | 858.66K | EPS | -0.46 | P/E | N/A | Forward P/E | -6.39 |
| Beta | 3.57 | Short Ratio | 0.56 | Inst. Own | 2.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.41 | 200-d Avg | 0.70 | 1yr Est | 3.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-08 | 2024-09 | 0 | -0.23 | N/A | N/A |
| 2024-08-08 | 2024-06 | 0 | -0.17 | N/A | N/A |
| 2024-05-10 | 2024-03 | 0 | -0.14 | N/A | N/A |
| 2024-03-27 | 2023-12 | 0 | N/A | N/A | N/A |
| 2023-11-13 | 2023-09 | 0 | -0.31 | N/A | N/A |
| 2023-08-10 | 2023-06 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-05 | Maxim Group | Downgrade | Buy | Hold |
| 2024-10-09 | Maxim Group | Upgrade | Buy |
Profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-09-29 | BERNHARD LESLIE | Director | 49.84K | Stock Award(Grant) |
| 2024-09-29 | ELSON MARILYN | Beneficial Owner of more than 10% of a Class of Security | 1.54M | Stock Award(Grant) |
| 2024-09-29 | HU BENJAMIN | Director | 340.64K | Stock Award(Grant) |
| 2024-10-27 | OWENS DAVID | Officer and Director | 148.29K | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Renaissance Technologies, LLC | 102.90K | 269.60K | 0.80% |
| 2024-09-29 | Geode Capital Management, LLC | 78.70K | 206.19K | 0.61% |
| 2024-09-29 | Citadel Advisors Llc | 58.19K | 152.44K | 0.45% |
| 2024-06-29 | CVI Holdings, LLC | 55.46K | 145.31K | 0.43% |
| 2024-09-29 | Susquehanna International Group, LLP | 42.38K | 111.04K | 0.33% |
| 2024-09-29 | Vanguard Group Inc | 31.78K | 83.26K | 0.25% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 52.24K | 136.86K | 0.41% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 31.78K | 83.26K | 0.25% |
| 2024-10-30 | Fidelity Total Market Index Fund | 17.08K | 44.75K | 0.13% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 12.30K | 32.22K | 0.10% |